Table 3.

Relapse-free rates after a standard or long regimen in patients with steroid-sensitive nephrotic syndrome

Study Group	Time (mo)
	6 (%)	12 (%)	18 (%)	24 (%)
This studya (standard, n=145)	57	44	41	39
ISKDCb (MCNS; standard, n=218)	45			28
APNc (long 12 wk, n=34)	76	62		49
APNc (standard, n=37)	51	35		19

ISKDC, International Study of Kidney Disease in Children; MCNS, minimal change nephrotic syndrome; APN, Arbeitsgemeinschaft für Pädiatrische Nephrologie.

^aData analyzed by the Kaplan–Meier method.

^bFrom reference 8.

^cFrom reference 16.